ReP USP - Resultado da busca

Artigo de periodico
Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial (2008)
Marin-Neto, José Antônio
Fonte: Lancet. Unidade: FMRP
Assunto: CARDIOLOGIA (CIRURGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, v. 371, n. 9627, p. 1839-1847, 2008Tradução . . Acesso em: 30 ago. 2024.
APA
Marin-Neto, J. A. (2008). Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, 371( 9627), 1839-1847.
NLM
Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 ago. 30 ]
Vancouver
Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 ago. 30 ]
Artigo de periodico
Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial (2008)
Marin-Neto, José Antônio
Fonte: Lancet. Unidade: FMRP
Assuntos: DOENÇAS CARDIOVASCULARES, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, v. 372, n. 9644, p. 1174-1183, 2008Tradução . . Acesso em: 30 ago. 2024.
APA
Marin-Neto, J. A. (2008). Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, 372( 9644), 1174-1183.
NLM
Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 ago. 30 ]
Vancouver
Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 ago. 30 ]
Artigo de periodico
Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled (2008)
Marin-Neto, José Antônio
Fonte: Lancet. Unidade: FMRP
Assuntos: DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, v. 372, n. 9638, p. 547-553, 2008Tradução . . Acesso em: 30 ago. 2024.
APA
Marin-Neto, J. A. (2008). Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, 372( 9638), 547-553.
NLM
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 ago. 30 ]
Vancouver
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 ago. 30 ]
Artigo de periodico
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial (2006)
Marin Neto, J A
Fonte: Lancet. Unidade: FMRP
Assunto: DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN NETO, J A. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, v. 367, n. 9526, p. 1903-1912, 2006Tradução . . Acesso em: 30 ago. 2024.
APA
Marin Neto, J. A. (2006). Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, 367( 9526), 1903-1912.
NLM
Marin Neto JA. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006 ; 367( 9526): 1903-1912.[citado 2024 ago. 30 ]
Vancouver
Marin Neto JA. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006 ; 367( 9526): 1903-1912.[citado 2024 ago. 30 ]
Artigo de periodico
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction (2001)
Marin-Neto, José Antônio
Fonte: Lancet. Unidade: FMRP
Assuntos: INFARTO DO MIOCÁRDIO (TRATAMENTO), ISQUEMIA MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet, v. 358, n. 9282, p. 605-613, 2001Tradução . . Acesso em: 30 ago. 2024.
APA
Marin-Neto, J. A. (2001). Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet, 358( 9282), 605-613.
NLM
Marin-Neto JA. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ; 358( 9282): 605-613.[citado 2024 ago. 30 ]
Vancouver
Marin-Neto JA. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001 ; 358( 9282): 605-613.[citado 2024 ago. 30 ]
Artigo de periodico
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study (2001)
Mehta, Shamir R.; Yusuf, Salim; Peters, Ron J. G.; Bertrand, Michel E.; Lewis, Basil S.; Natarajan, Madhu K.; Malmberg, Klas; Rupprecht, Hans-Jürgen; Zhao, Feng; Chrolavicius, Suzan; Copland, Ingrid; Fox, K. A. A.; Marin-Neto, José Antônio
Fonte: Lancet. Unidade: FMRP
Assuntos: FÁRMACOS SINTÉTICOS, MEDICAÇÃO ORAL, ISQUEMIA MIOCÁRDICA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Shamir R. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, v. 358, n. 9281, p. 527-533, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(01)05701-4. Acesso em: 30 ago. 2024.
APA
Mehta, S. R., Yusuf, S., Peters, R. J. G., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., et al. (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 358( 9281), 527-533. doi:10.1016/s0140-6736(01)05701-4
NLM
Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, Marin-Neto JA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [Internet]. Lancet. 2001 ; 358( 9281): 527-533.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/s0140-6736(01)05701-4
Vancouver
Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, Marin-Neto JA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [Internet]. Lancet. 2001 ; 358( 9281): 527-533.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/s0140-6736(01)05701-4
Artigo de periodico
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial (1999)
Werf, Frans Van de; Marin Neto, José Antonio
Fonte: Lancet. Unidade: FMRP
Assuntos: CARDIOPATIAS, MEDICINA INTERNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WERF, Frans Van de e MARIN NETO, José Antonio. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet, v. 354, p. 716-722, 1999Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(99)07403-6. Acesso em: 30 ago. 2024.
APA
Werf, F. V. de, & Marin Neto, J. A. (1999). Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet, 354, 716-722. doi:10.1016/s0140-6736(99)07403-6
NLM
Werf FV de, Marin Neto JA. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial [Internet]. Lancet. 1999 ; 354 716-722.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/s0140-6736(99)07403-6
Vancouver
Werf FV de, Marin Neto JA. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial [Internet]. Lancet. 1999 ; 354 716-722.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/s0140-6736(99)07403-6

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada